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Cardiac resynchronization therapy (CRT) has revolutionized
the treatment of advanced heart failure. However, effective
placement of a left ventricular (LV) pacing lead via the
coronary venous system is subject to anatomical constraints.
We present the case of a 78-year-old man with a history of
dilated cardiomyopathy and severe LV impairment. It was
not possible to implant a lead in the coronary sinus (CS) to
deliver biventricular pacing owing to atresia of the CS
ostium, so we implanted our patient with the ultrasound-
based WiCS-LV system and successfully delivered CRT.
Case report
A 78-year-old man with a history of dilated cardiomyopathy
and chronic atrial ﬁbrillation was scheduled for implantation
of a biventricular pacemaker/implantable cardioverter-
deﬁbrillator (CRT-D). Despite multiple attempts, it proved
impossible to catheterize the CS ostium, and so implantation
of an LV lead was abandoned. A 52-cm Tendril lead (St Jude
Medical) was implanted in the right atrial appendage, and a
58-cm Durata (St. Jude Medical, St. Paul, MN) single-coil
deﬁbrillation lead was ﬁxed in the apical interventricular
septum. These leads were connected to a Unify Assura
CRT-D device, implanted in a left prepectoral pocket with
the LV port capped.
Following this procedure, the patient underwent imaging
with contrast-enhanced computed tomography, with image
acquisition optimized for cardiac venous mapping. Complete
atresia of the CS ostium and persistence of a small-caliber left-
sided superior vena cava (SVC) was conﬁrmed. Multiple
enlarged Thebesian vessels were also noted drainingKEYWORDS Cardiac resynchronization therapy (CRT); Biventricular pace-
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).anteriorly into the left atrium (LA). Importantly, the volume-
rendered images also conﬁrmed an absence of any postero-
lateral target veins for delivery of a CS lead (Figure 1).
We therefore elected to deliver CRT therapy to our patient
endocardially by implanting the WiCS-LV system (EBR
Systems Inc, Sunnyvale, CA); ours was one of the ﬁrst
patients to be implanted following its commercial release.
WiCS-LV is the only leadless endocardial pacing system
for CRT. It uses ultrasound-based technology to transfer
energy acoustically from an ultrasound transmitter implanted
on an intercostal muscle to a small 12.7-mm ultrasound
receiver-electrode implanted on the LV endocardial wall.
The electrode transduces the acoustic energy to electrical
energy, which then stimulates the LV. The WiCS-LV system
is co-implanted with a right ventricular (RV) pacing system,
and the cycle for biventricular pacing commences with the
WiCS-LV system sensing the RV pacing pulse. Conﬁrma-
tion of the electrode in the LV is followed by LV stimulation
within 3 ms of the sensed RV pulse, and synchronous
biventricular pacing.
Preoperatively, the patient was assessed for suitability of
the WiCS-LV system. Transthoracic echocardiography was
performed to assess which, if any, intercostal spaces between
the 4th and 7th provided a minimum 1  3.5 cm acoustic
window to the LV without rib or lung encroachment.
Implantation of the system was performed in 2 stages. The
transmitter was surgically anchored in the previously iden-
tiﬁed intercostal space and the battery placed in the left mid-
axillary line. The following day the patient was implanted
with the passive endocardial electrode via the right femoral
artery and a retrograde aortic approach, as previously
described1 (Figure 2). We successfully targeted our endo-
cardial electrode placement to the site of latest mechanical
activation deﬁned by speckle-tracking 2D radial strain echo
analysis, following the protocol for optimal CS LV lead
placement in the TARGET2 and STARTER3 trials. QLV at
this site measured 104 ms.
At 1-month follow-up 94% biventricular pacing had been
achieved. QRS duration had reduced by 23%, from 150 mspen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 WiCS-LV is the world’s ﬁrst leadless endocardial
pacing system for cardiac resynchronization
therapy (CRT).
 The WiCS-LV system uses the conversion of acoustic
energy to electrical energy to pace the left
ventricle, timed off a right ventricular pacing pulse.
 This technology has the potential to overcome
some of the anatomical limitations of conventional
CRT and permit targeted site selection for left
ventricular pacing.
433Thomas et al Leadless CRTduring intrinsic conduction at baseline to 118 ms when
biventricular-paced with the WiCS-LV system; dyssyn-
chrony parameters had normalized (Figure 3); and there
was evidence of LV reverse remodeling with a 10%
reduction in end-systolic volume and an 8% increase in
ejection fraction observed. In addition, the patient experi-
enced a signiﬁcant subjective improvement in his heart
failure symptoms compatible with a 1-class reduction in
New York Heart Association at 1 month; and commensurate
with this improvement, he demonstrated a 14% increase in 6-
minute walk test distance and 36% reduction in his Minne-
sota Living with Heart Failure Questionnaire score.Discussion
The coronary venous system can pose a variety of obstacles to
the successful delivery of a CS pacing lead. The Thebesian and
Vieussens valves can obstruct catheter engagement and lead
passage, and heterogeneity in the caliber and distribution of the
posterior and marginal cardiac veins can preclude adequate
lead placement. However, in this instance, we encountered a
much less common obstacle involving complete atresia of the
right atrial ostium of the CS. The route for coronary venousFigure 1 (A) Computed tomography and volume-rendered image of the inferior
of the coronary sinus (CS). LA ¼ left atrium; LV ¼ left ventricle; RA ¼ right atri
oblique projections demonstrating a persistent left superior vena cava comm
posterolateral veins.return was provided by the persistent left SVC (PLSVC)
draining retrogradely into the innominate vein, right SVC, and
right atrium,4 and by Thebesian vessels draining into the LA.
Other reports of CS ostium atresia have documented direct
communication between the CS and LA,5,6 although this was
not present in our patient.
Successful delivery of an LV pacing lead via a PLSVC has
been previously reported in 2 patients with CS atresia.7,8
However, in these cases the caliber of the PLSVC was
adequate to successfully cannulate, and the ﬁrst-order coro-
nary venous tributaries provided acceptable targets. In our
patient, there were no posterior venous targets; and even if
there had been, the small caliber of the PLSVC, possibly due
to the coexistence of well-developed Thebesian veins, would
have made delivery of a pacing lead extremely challenging.
Whatever the anatomical limitations, failure to deliver and
secure a pacing lead in an appropriate target vein remains an
important limitation of conventional CRT implantation.
Failure to implant an LV lead occurred in 12% of patients
at their ﬁrst implant in the CARE-HF study, with over 50%
of failures being due to an inaccessible CS or target vein;9
and although implant techniques and technology have
evolved since the early days of CRT, implant failure remains
an important issue in a minority of patients. Furthermore, it is
also now appreciated that even if a CS lead can be delivered,
failure to achieve a position that is concordant with a late-
activated, viable region of myocardium is associated with
lack of beneﬁt from biventricular pacing.10 When prospec-
tively evaluated, it has been shown that lead placement
targeted to these regions provides the optimal response.2,3
However, the conﬁnes of cardiac venous anatomy do not
always permit the selection of these sites for pacing.
Surgical epicardial lead implantation and transseptal pro-
cedures have been performed in patients who could not be
paced transvenously; however, lead implantation in this way
appears to be associated with an increased morbidity and
mortality compared with conventional implant procedures.11
Transseptal techniques have been limited by concernssurface of the heart documenting complete absence of the right atrial ostium
um; RV ¼ right ventricle. (B) Volume-rendered images from left lateral and
unicating with the innominate vein, and an absence of any ﬁrst-order
Figure 3 Time to peak systolic strain for basal and mid–left ventricular segments depicted before (A) and after implantation of the WiCS-LV system (B). Note
the uniformity in segmental timing of peak strain following resynchronization, and the increase in overall circumferential strain values. SAX = short axis; B =
basal; M = mid; C.strain = circumferential strain.
Figure 2 Anterior (A) and lateral (B) ﬂuoroscopic projections demonstrating the components of the WiCS-LV system in situ.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016434regarding thromboembolic complications, the need for life-
long anticoagulation, interaction with the mitral valve, and
lack of dedicated lead extraction equipment. Nevertheless,
despite these limitations, this technique highlighted potential
physiological advantages of endocardial compared with
epicardial pacing, which included preservation of the trans-
mural activation sequence and faster impulse propagation.12
These beneﬁts appear to result in superior hemodynamic
performance.13 The WiCS-LV system, which delivers endo-
cardial LV pacing, allows access to all regions of the left
ventricle and is free from the well-known transseptal lead
complications; therefore, it has great potential value.
Conclusions
The feasibility and potential clinical efﬁcacy of the WiCS-
LV system have been demonstrated by the WISE CRTstudy14 and the preliminary results of the SELECT-LV
study,15 and further evaluation of this new technology is
ongoing within a European registry. We have demonstrated
that it can be used with good effect to overcome anatomical
constraints that would have previously proven a major
obstacle to successful CRT, and by allowing targeted
electrode placement it has the potential to maximize hemo-
dynamic beneﬁts and improve response.References
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